-
Health Canada Issues Warning About Vision Loss Related to Viagra, Cialis, and Levitra
Two Case Reports of NAION in Canada Prompt Drug-safety Alert on ED Drugs On July 26, 2005 Health Canada advised users of the erectile dysfunction drugs Viagra, Cialis, and Levitra to seek "immediate medical…
-
Psoriasis Drug Raptiva Increases the Risk of Serious Infections
July 2005 "Dear Doctor" Letter Warns About Some Blood Disorders, Also Genentech Inc. and the FDA announced recently that the drug company had added a new warning for the psoriasis drug Raptiva about an…
-
All NSAIDs May Be Linked to Increased Risk of Heart Attack (or Not)
June 2005 BMJ Article Calls Into Doubt Cardiovascular Safety of All NSAIDs There is new evidence that all selective and nonselective nonsteroidal anti-inflammatory drugs (NSAIDs) are associated with an increased risk of having a…
-
Case Report: Adderall-induced Heart Attack in Young Boy
Reports of Sudden Unexplained Death (SUD) Involving Children Being Studied by FDA After Adderall Withdrawn in Canada An article entitled "Myocardial infarction in an adolescent taking Adderall", by Pritesh J. Gandhi, et.al., was published…
-
Merck Did Not Test Safety of Vioxx on Heart Before it Was Brought to Market in 1999
Merck Epidemiologist Santanello: “At that time we didn’t think there was any risk.” According to The Associated Press (AP), Merck & Co.’s top epidemiologist, Nancy Santanello, gave testimony at the Ernst trial in Texas…
-
First Federal Court Vioxx Trial Set for November 2005 in New Orleans
Merck Maintains No "Global Settlement" Stance Despite Thousands of Vioxx Cases Filed to Date U.S. District Judge Eldon Fallon, the federal court judge overseeing the Vioxx MDL (Multi-district Litigation), announced on July 19, 2005…
